9-6645390-C-T
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_000170.3(GLDC):c.110G>A(p.Ser37Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000402 in 1,517,388 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S37R) has been classified as Uncertain significance.
Frequency
Consequence
NM_000170.3 missense
Scores
Clinical Significance
Conservation
Publications
- glycine encephalopathyInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Myriad Women’s Health, Labcorp Genetics (formerly Invitae), ClinGen
- glycine encephalopathy 1Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
- infantile glycine encephalopathyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- neonatal glycine encephalopathyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- atypical glycine encephalopathyInheritance: Unknown Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| GLDC | NM_000170.3 | c.110G>A | p.Ser37Asn | missense_variant | Exon 1 of 25 | ENST00000321612.8 | NP_000161.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| GLDC | ENST00000321612.8 | c.110G>A | p.Ser37Asn | missense_variant | Exon 1 of 25 | 1 | NM_000170.3 | ENSP00000370737.4 | ||
| LINC02851 | ENST00000813373.1 | n.124+464C>T | intron_variant | Intron 1 of 2 | ||||||
| LINC02851 | ENST00000813380.1 | n.405+464C>T | intron_variant | Intron 1 of 2 |
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 152002Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000337 AC: 4AN: 118546 AF XY: 0.0000306 show subpopulations
GnomAD4 exome AF: 0.0000286 AC: 39AN: 1365276Hom.: 0 Cov.: 32 AF XY: 0.0000327 AC XY: 22AN XY: 673576 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000145 AC: 22AN: 152112Hom.: 0 Cov.: 33 AF XY: 0.000175 AC XY: 13AN XY: 74384 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Glycine encephalopathy Uncertain:2
This sequence change replaces serine, which is neutral and polar, with asparagine, which is neutral and polar, at codon 37 of the GLDC protein (p.Ser37Asn). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with GLDC-related conditions. ClinVar contains an entry for this variant (Variation ID: 531762). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt GLDC protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
- -
not provided Uncertain:1
In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at